Author Disclosure Statement
Diabetes
DIABETES
A.B. reports: receiving speaker fees from Novo Nordisk, Sanofi, Dexcom, and Abbott Diabetes Care. C.B. reports: receiving speaker fees from ABCD Diabetes Technology Network. S.H. reports: receiving speaker and advisory board fees from Dexcom, Medtronic, Sanofi, and Ypsomed; and being Director of ASK Diabetes Ltd., he receives consulting/training fees from CamDiab Ltd. E.M.S. reports: receiving honoraria for talks given to Abbott Diabetes Care and Eli-Lilly. R.H. reports: receiving speaker honoraria from Eli Lilly, Dexcom, and Novo Nordisk; receiving license and/or consultancy fees from B. Braun and Abbott Diabetes Care; patents related to closed-loop; and being Director at CamDiab. H.R.M. reports: sitting on the Medtronic European Scientific Advisory Board and receiving speaker honoraria from Dexcom, Abbott Diabetes Care, Medtronic, and Novo Nordisk. D.R., J.L., R.I.H., B.K., K.B.-K., C.C., A.R.D., K.F.H., T.T.M.L., R.S.L., D.R.M., A.M., G.R., R.M.R., and S.L.W. have no conflicts of interest to declare.